{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T16:51:37Z","timestamp":1781974297828,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,20]]},"DOI":"10.7759\/cureus.111199","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T16:29:16Z","timestamp":1781972956000},"source":"Crossref","is-referenced-by-count":0,"title":["Barriers to Guideline-Based Management of Esophageal Carcinoma: A Narrative Review With Special Reference to North East India"],"prefix":"10.7759","author":[{"given":"Sumit","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deiwakor","family":"Chyrmang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswajit","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamajyoti","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binoy","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000003420","article-title":"Global esophageal cancer epidemiology in 2022 and predictions for 2050: a comprehensive analysis and projections based on GLOBOCAN data","volume":"137","author":"Qi L","year":"2024","unstructured":"Qi L, Sun M, Liu W, et al.. Global esophageal cancer epidemiology in 2022 and predictions for 2050: a comprehensive analysis and projections based on GLOBOCAN data. Chin Med J (Engl). 2024, 137:3108-16. 10.1097\/CM9.0000000000003420","journal-title":"Chin Med J (Engl)"},{"key":"ref2","unstructured":"Profile of cancer and related health indicators in the North East Region of India-2021. (2021). Accessed. May 24, 2026: https:\/\/ncdirindia.org\/All_Reports\/NorthEast2021\/Default.aspx."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_347_20","article-title":"Cancer scenario in North-East India & need for an appropriate research agenda","volume":"154","author":"Shanker N","year":"2021","unstructured":"Shanker N, Mathur P, Das P, Sathishkumar K, Martina Shalini AJ, Chaturvedi M. Cancer scenario in North-East India & need for an appropriate research agenda. Indian J Med Res. 2021, 154:27-35. 10.4103\/ijmr.IJMR_347_20","journal-title":"Indian J Med Res"},{"key":"ref4","unstructured":"Consensus document for management of esophageal cancer. (2017). Accessed. May 24, 2026: https:\/\/www.icmr.gov.in\/icmrobject\/custom_data\/pdf\/resource-guidelines\/Esophagus%20final%20ICMR2014_0.pdf."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.0019","article-title":"Esophageal and esophagogastric junction cancers, version 2.2023, NCCN Clinical Practice Guidelines in Oncology","volume":"21","author":"Ajani JA","year":"2023","unstructured":"Ajani JA, D'Amico TA, Bentrem DJ, et al.. Esophageal and esophagogastric junction cancers, version 2.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023, 21:393-422. 10.6004\/jnccn.2023.0019","journal-title":"J Natl Compr Canc Netw"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.07.003","article-title":"Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Obermannov\u00e1 R","year":"2022","unstructured":"Obermannov\u00e1 R, Alsina M, Cervantes A, et al.. Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022, 33:992-1004. 10.1016\/j.annonc.2022.07.003","journal-title":"Ann Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00866","article-title":"Treatment of locally advanced esophageal carcinoma: ASCO guideline","volume":"38","author":"Shah MA","year":"2020","unstructured":"Shah MA, Kennedy EB, Catenacci DV, et al.. Treatment of locally advanced esophageal carcinoma: ASCO guideline. J Clin Oncol. 2020, 38:2677-94. 10.1200\/JCO.20.00866","journal-title":"J Clin Oncol"},{"key":"ref8","unstructured":"Esophageal cancer treatment (PDQ\u00ae)-health professional version. (2025). Accessed. May 24, 2026: https:\/\/www.cancer.gov\/types\/esophageal\/hp\/esophageal-treatment-pdq."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"van Hagen P","year":"2012","unstructured":"van Hagen P, Hulshof MC, van Lanschot JJ, et al.. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012, 366:2074-84. 10.1056\/NEJMoa1112088","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32557-1","article-title":"Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2\/3 trial","volume":"393","author":"Al-Batran SE","year":"2019","unstructured":"Al-Batran SE, Homann N, Pauligk C, et al.. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2\/3 trial. Lancet. 2019, 393:1948-57. 10.1016\/S0140-6736(18)32557-1","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2032125","article-title":"Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer","volume":"384","author":"Kelly RJ","year":"2021","unstructured":"Kelly RJ, Ajani JA, Kuzdzal J, et al.. Adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer. N Engl J Med. 2021, 384:1191-203. 10.1056\/NEJMoa2032125","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.31557\/apjcc.2023.8.1.175-179","article-title":"Facilitating cancer care through Ayushman Bharat Scheme (PMJAY) in rural places of India: a narrative review","volume":"8","author":"Sinha SK","year":"2023","unstructured":"Sinha SK, Singh P, Sinha A. Facilitating cancer care through Ayushman Bharat Scheme (PMJAY) in rural places of India: a narrative review. Asian Pacific J Cancer Care. 2023, 8:175-9. 10.31557\/apjcc.2023.8.1.175-179","journal-title":"Asian Pacific J Cancer Care"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare13212748","article-title":"Insights into cancer patients' experiences and needs in the northeast region of India: a qualitative study","volume":"13","author":"Dhar RR","year":"2025","unstructured":"Dhar RR, Bhageerathy R, Holla R, Mawlong A. Insights into cancer patients' experiences and needs in the northeast region of India: a qualitative study. Healthcare (Basel). 2025, 13:10.3390\/healthcare13212748","journal-title":"Healthcare (Basel)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.25259\/IJMR_742_2025","article-title":"Barriers in implementing cancer prevention programme in North Eastern India: a case study from Meghalaya","volume":"162","author":"Pohsnem F","year":"2025","unstructured":"Pohsnem F, Nongrum MS, Sarkar R, Albert S. Barriers in implementing cancer prevention programme in North Eastern India: a case study from Meghalaya. Indian J Med Res. 2025, 162:771-8. 10.25259\/IJMR_742_2025","journal-title":"Indian J Med Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-024-15627-9","article-title":"Understanding barriers to guideline-concordant treatment in foregut cancer: from data to solutions","volume":"31","author":"Fonseca AL","year":"2024","unstructured":"Fonseca AL, Ahmad R, Amin K, et al.. Understanding barriers to guideline-concordant treatment in foregut cancer: from data to solutions. Ann Surg Oncol. 2024, 31:6007-16. 10.1245\/s10434-024-15627-9","journal-title":"Ann Surg Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s13691-024-00660-y","article-title":"Capecitabine and oxaliplatin induced Steven-Johnson syndrome following nivolumab in a patient of metastatic esophageal carcinoma","volume":"13","author":"Kumar S","year":"2024","unstructured":"Kumar S, Nongkynrih A, Dey B, Jagtap V, Lamba R, Chyrmang D. Capecitabine and oxaliplatin induced Steven-Johnson syndrome following nivolumab in a patient of metastatic esophageal carcinoma. Int Cancer Conf J. 2024, 13:167-70. 10.1007\/s13691-024-00660-y","journal-title":"Int Cancer Conf J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2014\/7428.4309","article-title":"Immunohistochemical analysis of P53 and PRB in esophageal squamous cell carcinoma","volume":"8","author":"Dey B","year":"2014","unstructured":"Dey B, Raphael V, Khonglah Y, Lynrah KG. Immunohistochemical analysis of P53 and PRB in esophageal squamous cell carcinoma. J Clin Diagn Res. 2014, 8:FC01-3. 10.7860\/JCDR\/2014\/7428.4309","journal-title":"J Clin Diagn Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.839516","article-title":"Effects of Enteral Nutrition on Patients With Oesophageal Carcinoma Treated With Concurrent Chemoradiotherapy: A Prospective, Multicentre, Randomised, Controlled Study","volume":"12","author":"Lyu J","year":"2022","unstructured":"Lyu J, Shi A, Li T, et al.. Effects of Enteral Nutrition on Patients With Oesophageal Carcinoma Treated With Concurrent Chemoradiotherapy: A Prospective, Multicentre, Randomised, Controlled Study. Front Oncol. 2022, 12:839516. 10.3389\/fonc.2022.839516","journal-title":"Front Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-4794755\/v1","article-title":"Study Protocol: a mixed method and multimethod study of implementation and impact of Ayushman Bharat- Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) scheme in Assam state [Preprint]","author":"Verma V","year":"2024","unstructured":"Verma V, Nath DC, Chetri R, et al.. Study Protocol: a mixed method and multimethod study of implementation and impact of Ayushman Bharat- Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) scheme in Assam state [Preprint]. Res Sq. 2024, 10.21203\/rs.3.rs-4794755\/v1","journal-title":"Res Sq"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0268858","article-title":"An analysis of government-sponsored health insurance enrolment and claims data from Meghalaya: Insights into the provision of health care in North East India","volume":"17","author":"Dutta EK","year":"2022","unstructured":"Dutta EK, Kumar S, Venkatachalam S, Downey LE, Albert S. An analysis of government-sponsored health insurance enrolment and claims data from Meghalaya: Insights into the provision of health care in North East India. PLoS One. 2022, 17:e0268858. 10.1371\/journal.pone.0268858","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2022.1342","article-title":"Journeys: understanding access, affordability and disruptions to cancer care in India","volume":"16","author":"Datta SS","year":"2022","unstructured":"Datta SS, Ghose S, Ghosh M, Jain A, Mandal S, Chakraborty S, Caduff C. Journeys: understanding access, affordability and disruptions to cancer care in India. ecancer. 2022, 16:1342. 10.3332\/ecancer.2022.1342","journal-title":"ecancer"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.25259\/IJMR_1714_2025","article-title":"Barriers and facilitators to cancer care in the Northeast region, India: a scoping review","volume":"163","author":"Dhar RR","year":"2026","unstructured":"Dhar RR, Bhageerathy R, Holla R. Barriers and facilitators to cancer care in the Northeast region, India: a scoping review. Indian J Med Res. 2026, 163:345-54. 10.25259\/IJMR_1714_2025","journal-title":"Indian J Med Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1714193","article-title":"Occult esophageal squamous cell carcinoma presenting with multiple bony osteolytic lesions clinically mimicking multiple myeloma: a diagnostic dilemma","volume":"12","author":"Lyngdoh BS","year":"2020","unstructured":"Lyngdoh BS, Dey B, Raphael V, Tiewsoh I. Occult esophageal squamous cell carcinoma presenting with multiple bony osteolytic lesions clinically mimicking multiple myeloma: a diagnostic dilemma. J Lab Physicians. 2020, 12:76-8. 10.1055\/s-0040-1714193","journal-title":"J Lab Physicians"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.25259\/ijmr_2136_23","article-title":"Factors influencing delayed cancer health seeking in Meghalaya, Northeast India: a qualitative study","volume":"160","author":"Dkhar B","year":"2024","unstructured":"Dkhar B, Khongwir C, Mawrie UG, et al.. Factors influencing delayed cancer health seeking in Meghalaya, Northeast India: a qualitative study. Indian J Med Res. 2024, 160:201-9. 10.25259\/ijmr_2136_23","journal-title":"Indian J Med Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/hpm.3667","article-title":"Barriers in quest for cancer care access in two states of northeast India","volume":"38","author":"Kuru D","year":"2023","unstructured":"Kuru D, Kumar K A, Chaturvedi P. Barriers in quest for cancer care access in two states of northeast India. Int J Health Plann Manage. 2023, 38:1396-408. 10.1002\/hpm.3667","journal-title":"Int J Health Plann Manage"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-025-17795-8","article-title":"Attrition after neoadjuvant chemotherapy in foregut cancer: experience at a tertiary center in the Deep South","volume":"32","author":"Holland M","year":"2025","unstructured":"Holland M, Sanghera J, Liapis I, et al.. Attrition after neoadjuvant chemotherapy in foregut cancer: experience at a tertiary center in the Deep South. Ann Surg Oncol. 2025, 32:7740-50. 10.1245\/s10434-025-17795-8","journal-title":"Ann Surg Oncol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5882","article-title":"Influence of a patient navigation program on timeliness of care in patients with esophageal cancer","volume":"12","author":"Arora N","year":"2023","unstructured":"Arora N, Lo M, Hanna NM, et al.. Influence of a patient navigation program on timeliness of care in patients with esophageal cancer. Cancer Med. 2023, 12:11907-14. 10.1002\/cam4.5882","journal-title":"Cancer Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4103\/0975-9476.100171","article-title":"Traditional healing practice and folk medicines used by Mishing community of North East India","volume":"3","author":"Shankar R","year":"2012","unstructured":"Shankar R, Lavekar GS, Deb S, Sharma BK. Traditional healing practice and folk medicines used by Mishing community of North East India. J Ayurveda Integr Med. 2012, 3:124-9. 10.4103\/0975-9476.100171","journal-title":"J Ayurveda Integr Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0338482","article-title":"The effectiveness of Question Prompt Lists (QPL) in enhancing treatment outcomes for cancer patients among tribal population in Meghalaya: a quasi-experimental design","volume":"20","author":"Dhar RR","year":"2025","unstructured":"Dhar RR, Reshmi B, Holla R, Jaganathan V, Josten K, Mawlong A. The effectiveness of Question Prompt Lists (QPL) in enhancing treatment outcomes for cancer patients among tribal population in Meghalaya: a quasi-experimental design. PLoS One. 2025, 20:e0338482. 10.1371\/journal.pone.0338482","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.52247","article-title":"Impact of COVID-19 on cancer patients: an experience from a tertiary care center in Northeast India","volume":"16","author":"Kumar S","year":"2024","unstructured":"Kumar S, Singh B, Dey B, Jagtap VK, Verma S, Nongkynrih A. Impact of COVID-19 on cancer patients: an experience from a tertiary care center in Northeast India. Cureus. 2024, 16:e52247. 10.7759\/cureus.52247","journal-title":"Cureus"},{"key":"ref31","article-title":"Expression of cyclin D1 and p16 in esophageal squamous cell carcinoma","volume":"7","author":"Dey B","year":"2015","unstructured":"Dey B, Raphael V, Khonglah Y, GiriLynrah K. Expression of cyclin D1 and p16 in esophageal squamous cell carcinoma. Middle East J Dig Dis. 2015, 7:220-5.","journal-title":"Middle East J Dig Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/503457-barriers-to-guideline-based-management-of-esophageal-carcinoma-a-narrative-review-with-special-reference-to-north-east-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T16:29:19Z","timestamp":1781972959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/503457-barriers-to-guideline-based-management-of-esophageal-carcinoma-a-narrative-review-with-special-reference-to-north-east-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.111199","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,20]]}}}